Remove Labelling Remove Vaccines Remove White Paper
article thumbnail

How Berlinger’s climate-focused innovation is helping to reduce, remove and offset emissions from the pharmaceutical supply

Pharmaceutical Technology

And despite the recent pandemic that forced the industry to develop and deliver treatments and vaccines all over the world, the issue of reducing emissions has remained high on industry leaders’ agendas. Download the white paper to learn more. [1] Industry awareness of the issues. Linda Schwär, VP Marketing, Berlinger & Co.

article thumbnail

CMO Moves: Regulatory catalysts for drug manufacturing – March 2023

Pharmaceutical Technology

A few weeks later, the EC extended the approval label of AstraZeneca’s Forxiga (dapagliflozin) to include the treatment of symptomatic hearth failure. The vaccine ACI-24.060 elicited an anti-Abeta antibody response in the first patient cohort after six weeks, as per the results.

article thumbnail

Inflation, drug pricing and reimbursement constraints will challenge pharma sector

Pharmaceutical Technology

The swift development of COVID-19 vaccines was an unprecedented scientific and collaborative achievement by government, regulators, research institutions, and the pharmaceutical industry. The pharmaceutical industry has long been labelled as a recession-proof—stable demand for medicines and new treatment options acts as a protective barrier.